Diretic-DS40 mg+50 mg

Edema Associated with Congestive Heart Failure (Established)

Diretic-DS 40 mg+50 mg is an established combination for managing fluid retention (edema) in chronic congestive heart failure. The loop diuretic component produces a strong natriuretic and diuretic effect, while the potassium-sparing component offsets the potassium loss that furosemide alone would cause.

Edema in Hepatic Cirrhosis with Ascites (Established)

Diretic-DS 40 mg+50 mg is established for edema and ascites due to hepatic cirrhosis, a setting in which secondary hyperaldosteronism is common; the spironolactone component addresses this mechanism directly while the furosemide component adds potent fluid removal.

Edema in Nephrotic Syndrome (Established)

Diretic-DS 40 mg+50 mg may be used for edema associated with nephrotic syndrome, combining diuretic efficacy with a reduced risk of drug-induced hypokalemia.

Resistant Edema Associated with Secondary Hyperaldosteronism (Established)

Diretic-DS 40 mg+50 mg is indicated for resistant edema linked to secondary hyperaldosteronism, a state in which the potassium-sparing, aldosterone-blocking action of the spironolactone component is particularly useful.

Hyperaldosteronism (Guideline-Supported, Component-Based)

The spironolactone component of Diretic-DS 40 mg+50 mg is used in the management of primary hyperaldosteronism, both before surgery and for long-term maintenance therapy when surgery is not performed.

Essential Hypertension (Adjunct)

Diretic-DS 40 mg+50 mg may be used as an adjunct treatment for essential hypertension when a combined diuretic effect with potassium conservation is clinically appropriate, generally after simpler regimens have been considered.

Each tablet of Diretic-DS 40 mg+50 mg contains two active ingredients: Furosemide and Spironolactone. In Bangladesh, Diretic-DS 40 mg+50 mg is marketed in two fixed-dose strengths: Furosemide 20 mg + Spironolactone 50 mg, and Furosemide 40 mg + Spironolactone 50 mg.

Diretic-DS 40 mg+50 mg is a fixed-dose combination medicine that brings together a loop diuretic (Furosemide) and a potassium-sparing diuretic (Spironolactone) in a single tablet. It is used to help the body remove excess fluid in conditions such as heart failure, liver cirrhosis with ascites, and certain kidney disorders. The combination is specifically designed so that the potassium-conserving effect of the spironolactone component balances the potassium loss caused by the furosemide component. Diretic-DS 40 mg+50 mg should only be taken on the advice and under the supervision of a registered physician, with periodic monitoring of kidney function and blood electrolytes. It is not a treatment to be started or stopped without medical guidance.

Diuretic (Loop Diuretic + Potassium-Sparing Diuretic combination)

Diretic-DS 40 mg+50 mg combines two diuretics with different pharmacokinetic profiles. The furosemide component is well absorbed orally, is extensively (91-99%) bound to plasma proteins, has an onset of diuretic action within about 1 hour, a peak effect at 1-2 hours, and a duration of action of roughly 6-8 hours; it is metabolized mainly to furosemide glucuronide and eliminated chiefly by the kidneys, with an elimination half-life of approximately 2 hours. The spironolactone component reaches peak plasma concentration around 2.6 hours after dosing (absorption is increased when taken with food), is more than 90% protein bound, and is rapidly and extensively metabolized to active metabolites, including canrenone, which have longer half-lives of roughly 13.8-16.5 hours; the parent drug itself has a short half-life of about 1.4 hours, and its metabolites are eliminated mainly via the kidneys.

• Take Diretic-DS 40 mg+50 mg exactly as prescribed by your doctor, generally once daily, preferably in the morning to avoid nighttime urination.
• Swallow the tablet with a glass of water; it may be taken with or without food, though taking it with food may help reduce stomach upset.
• Do not stop Diretic-DS 40 mg+50 mg suddenly or change the dose on your own, even if you feel better.
• Attend all scheduled blood tests, as your doctor will need to monitor your serum potassium, sodium, and kidney function regularly while you are taking Diretic-DS 40 mg+50 mg.
• Avoid potassium supplements, salt substitutes containing potassium, and high-potassium diets unless your doctor specifically approves them, since Diretic-DS 40 mg+50 mg can raise blood potassium levels.
• Stand up slowly from sitting or lying positions, as Diretic-DS 40 mg+50 mg can cause dizziness or lightheadedness, especially early in treatment.
• Keep well hydrated as advised by your doctor, and report excessive thirst, muscle cramps, or reduced urination promptly.

• ACE inhibitors and ARBs: Combined use with Diretic-DS 40 mg+50 mg increases the risk of significant hyperkalemia because both the spironolactone component and these drugs reduce potassium excretion.
• Potassium supplements and potassium-sparing agents: Concurrent use with Diretic-DS 40 mg+50 mg raises the risk of dangerous hyperkalemia and should generally be avoided.
• NSAIDs (e.g., ibuprofen, indomethacin): May reduce the diuretic and antihypertensive effect of Diretic-DS 40 mg+50 mg and increase the risk of kidney impairment, particularly with regular use.
• Lithium: Diretic-DS 40 mg+50 mg reduces renal clearance of lithium, increasing the risk of lithium toxicity; this combination should generally be avoided or lithium levels monitored closely.
• Digoxin: The spironolactone component can raise digoxin levels, and electrolyte shifts caused by Diretic-DS 40 mg+50 mg (particularly changes in potassium) can increase the risk of digoxin-related cardiac arrhythmias.
• Aminoglycoside antibiotics: The furosemide component may increase the risk of ototoxicity (hearing damage) when combined with aminoglycosides, especially in patients with reduced kidney function.
• Corticosteroids: May add to the potassium-lowering effect of the furosemide component, increasing the risk of hypokalemia when the diuretics' balancing effect is offset.
• Sucralfate: May reduce the diuretic effect of the furosemide component; doses should be separated by at least two hours if co-administration is necessary.
• Antidiabetic drugs: Diretic-DS 40 mg+50 mg may alter blood glucose control; monitoring is advised in patients with diabetes.

Common Side Effects

Headache, dizziness, drowsiness, gastrointestinal upset (nausea, vomiting, diarrhea, cramping), muscle cramps, orthostatic (postural) lightheadedness, and menstrual irregularities or breast tenderness/enlargement (gynecomastia) related to the spironolactone component, which is usually reversible on stopping treatment.

Serious Side Effects (Seek Medical Attention)

Signs of hyperkalemia (muscle weakness, irregular heartbeat, tingling) — see Precautions for full details. Signs of significant dehydration or electrolyte disturbance (severe thirst, confusion, reduced urination, very low blood pressure) — see Precautions for full details. Also seek prompt medical attention for: hearing changes or ringing in the ears (ototoxicity), irregular heartbeat, severe or persistent dizziness/fainting, unusual bleeding or bruising, signs of severe skin reaction (blistering, peeling skin, widespread rash — rarely including Stevens-Johnson syndrome), yellowing of the skin or eyes (jaundice), and signs of blood disorders such as unusual fatigue, fever, or frequent infections.

Pregnancy

Diretic-DS 40 mg+50 mg is not recommended for routine use in pregnancy and should be used only if a physician determines the potential benefit clearly justifies the potential risk. The furosemide component has caused fetal harm in animal studies at high doses, and diuretics in general are not appropriate for treating simple dependent edema of pregnancy. The spironolactone component has an antiandrogenic mechanism of action that, based on this mechanism and animal data, may affect sexual development of a male fetus; it should generally be avoided in pregnancy unless no safer alternative exists, and any use should involve a discussion of fetal risk with the prescribing physician.

Breastfeeding

Both components of Diretic-DS 40 mg+50 mg pass into breast milk. Furosemide may also suppress lactation. Because of these effects, Diretic-DS 40 mg+50 mg is generally not recommended during breastfeeding unless a physician judges it necessary, in which case alternative infant feeding should be discussed.

• Hyperkalemia risk: The spironolactone component of Diretic-DS 40 mg+50 mg can cause elevated blood potassium, which may be serious or life-threatening, particularly in patients with reduced kidney function, diabetes, or those taking ACE inhibitors, ARBs, potassium supplements, or other potassium-sparing drugs. Serum potassium should be checked before starting Diretic-DS 40 mg+50 mg, within about one week of starting or changing the dose, and periodically thereafter; patients should be told to report muscle weakness, irregular heartbeat, or tingling promptly.
• Dehydration and electrolyte disturbance: The furosemide component of Diretic-DS 40 mg+50 mg can cause vigorous diuresis leading to dehydration, low blood volume, and disturbances of sodium, chloride, and other electrolytes, which can in turn cause dizziness, low blood pressure, circulatory collapse, and (particularly in the elderly or those on other blood-pressure-lowering drugs) an increased risk of falls or thrombotic events. Fluid status, blood pressure, and electrolytes should be monitored regularly, especially early in treatment or after dose changes.
• Renal function monitoring: Excessive diuresis can worsen kidney function; renal function should be checked periodically, and doses reassessed if it declines.
• Diabetes: Diretic-DS 40 mg+50 mg may affect blood glucose control; blood sugar should be monitored in patients with diabetes.
• Benign prostatic hyperplasia: Caution is needed, as diuretic-induced increases in urine output can worsen urinary symptoms in men with prostate enlargement.
• Gynecomastia: Breast enlargement or tenderness can occur with the spironolactone component and is usually reversible when the drug is stopped.
• Ototoxicity: Hearing disturbances have been reported with the furosemide component, more often with high doses, rapid administration, or existing kidney impairment; report any hearing changes or ringing in the ears.
• Photosensitivity: Diretic-DS 40 mg+50 mg may increase skin sensitivity to sunlight; sun protection is advisable.

Overdose of Diretic-DS 40 mg+50 mg most commonly presents with effects related to excessive diuresis and electrolyte disturbance, including dehydration, low blood pressure, dizziness or fainting, muscle weakness or cramps, confusion, drowsiness, nausea, vomiting, and diarrhea; irregular heartbeat can occur due to electrolyte imbalance. Do not induce vomiting unless specifically directed to do so by a doctor or poison control center. If an overdose of Diretic-DS 40 mg+50 mg is suspected, contact emergency medical services or a poison control center immediately, or go to the nearest hospital. Treatment is supportive and typically involves fluid and electrolyte replacement, monitoring of kidney function, heart rhythm, and blood pressure under medical supervision.

Store Diretic-DS 40 mg+50 mg according to the instructions on the product label. Unless the label states otherwise, keep in a cool, dry place away from direct sunlight and moisture, and keep out of the reach and sight of children.

Children

Diretic-DS 40 mg+50 mg is not recommended for use in children; the fixed-dose combination has not been established as safe and effective in the pediatric population.

Elderly

Elderly patients should use Diretic-DS 40 mg+50 mg with caution, as they are more susceptible to dehydration, electrolyte disturbances, orthostatic hypotension, and falls; kidney function and electrolytes should be monitored closely.

Renal Impairment

Diretic-DS 40 mg+50 mg is contraindicated in severe renal impairment, acute renal failure, and anuria. In milder renal impairment, it should be used with caution and close monitoring of potassium and kidney function, since both dehydration and hyperkalemia risks are increased.

Hepatic Impairment

In patients with hepatic cirrhosis and ascites, Diretic-DS 40 mg+50 mg should be used carefully, since rapid or excessive diuresis and electrolyte shifts can precipitate hepatic encephalopathy; treatment should be supervised closely with monitoring of electrolytes and mental status.

Other Populations

Patients with diabetes or benign prostatic hyperplasia should use Diretic-DS 40 mg+50 mg with added caution and monitoring, as described in Precautions and Warnings.

The duration of treatment with Diretic-DS 40 mg+50 mg depends on the indication and is determined by the treating physician. In congestive heart failure, hepatic cirrhosis with ascites, and nephrotic syndrome, Diretic-DS 40 mg+50 mg is typically used long-term as part of chronic disease management, with periodic review of dose, kidney function, and electrolytes. In essential hypertension, it is likewise generally a long-term therapy, adjusted over time based on blood pressure control. Treatment should never be stopped or extended without medical advice.

Loop diuretic + Potassium-sparing diuretic (aldosterone antagonist) fixed-dose combination

Diretic-DS 40 mg+50 mg works through two complementary mechanisms. The furosemide component inhibits the sodium-potassium-2 chloride (Na+/K+/2Cl-) co-transporter in the thick ascending limb of the loop of Henle, blocking reabsorption of sodium, chloride, and potassium and producing a potent diuresis, but with an accompanying loss of potassium. The spironolactone component is a competitive antagonist of aldosterone at mineralocorticoid receptors in the distal renal tubule, reducing sodium reabsorption and potassium excretion there. By combining the two, Diretic-DS 40 mg+50 mg achieves strong diuresis from the loop diuretic component while the aldosterone-blocking action of the potassium-sparing component offsets the potassium loss that furosemide alone would cause.

Pediatric use of Diretic-DS 40 mg+50 mg as a fixed-dose combination is not established, and it is generally not recommended for children. Where diuretic therapy is required in children, individual components are typically dosed and monitored separately by a pediatric specialist rather than using the combined tablet.